The Federal Trade Commission is holding a public workshop in March to examine U.S. healthcare competition issues as healthcare spending swallows up a significant part of federal and state budgets. Among the topics up for discussion, according to reports, are retail clinics and telemedicine.
The Pharmaceutical Research and Manufacturers of America and the National Minority Quality Forum announced on Wednesday a first-of-its-kind national campaign to help increase diversity in clinical trials.
The National Retail Federation is urging Congress to pass legislation that would require online and remote sellers to collect state and local sales taxes, telling a House committee that lawmakers should level the playing field between local retailers and out-of-state competitors.
The Centers for Medicare and Medicaid Services has decided not to move forward on several of the proposed provisions of the Medicare Advantage and Part D prescription drug program, according to reports.
In anticipation of the March 13 deadline for comments on the FDA's proposed rule on prescription generic drug labeling, 21 health industry groups submitted a new letter to the agency on Thursday, raising concerns about the proposed regulation.
Costco reported on Thursday a decrease in second-quarter net income, which it attributed to weaker sales and gross margin results in certain non-foods merchandise categories, weaker gross margins in its fresh foods business and lower reported international profits.
Scientists from the Council for Responsible Nutrition addressed a key group of healthcare practitioners regarding recent studies on multivitamin and multimineral supplements in the Annals of Internal Medicine through a review published in the Natural Medicine Journal, the journal of the American Association of Naturopathic Physicians.
In what could turn into a significant change of how retail pharmacy supplies hydrocodone combination products, the Drug Enforcement Administration last week published in the Federal Register a Notice of Proposed Rulemaking to move HCPs from Schedule III to Schedule II, as recommended by the assistant secretary for health of the Department of Health and Human Services and as supported by the DEA’s evaluation of relevant data.
The Generic Pharmaceutical Association on Friday hosted a Congressional briefing highlighting the economic impact the Food and Drug Administration’s proposed rule on prescription labeling that would allow for label changes without prior FDA approval.
Last week, more than 30 organizations — including the American Medical Association, Infectious Diseases Society of America and Pew Charitable Trusts — urged Congressional leaders to strengthen the labeling requirements for drugs approved under the proposed Antibiotic Development to Advance Patient Treatment Act of 2013 (ADAPT Act) limited population approval pathway, which will streamline regulatory approval for antibiotics.
"The problem [of counterfeit medicines] is so big, disperse and complex that it requires a sweeping coordinated global response," wrote Scott LaGanga, executive director of the Partnership for Safe Medicines and SVP public affairs and advocacy for PhRMA in a blog published by The Hill on Saturday.
To provide pharmacist a detail description of each step in the comprehensive medication review, the American Pharmacists Association has published How to Conduct a Comprehensive Medication Review: A Guidebook for Pharmacists, the association has announced.
The Consumer Healthcare Products Association earlier this week voiced support for keeping over-the-counter bronchodilators in the OTC Monograph during a recent meeting of the Food and Drug Administration’s Nonprescription Drugs Advisory Committee.
New research released Tuesday found that when it comes to treating pain, a growing number of consumers know how to safely use medicines with acetaminophen and to avoid accidental overdose and liver damage.